← Back to Search

Medical Device

Novel Endoluminal Clinical TreAtment of Reflux (NECTAR Trial)

N/A
Waitlist Available
Research Sponsored by Impleo Medical Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months

Summary

This trial is testing a medication called Aluvra to see if it can help people with GERD. GERD is a condition that causes heartburn and acid reflux. The study will check if Aluvra can safely reduce these symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Efficacy of Aluvra- Esophageal PH
Efficacy of Aluvra- GERD HRQL

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Aluvra™Experimental Treatment1 Intervention
Endoscopic injection of bulking agent (Aluvra) to the lower esophageal sphincter
Group II: SalinePlacebo Group1 Intervention
Endoscopic injection of saline

Find a Location

Who is running the clinical trial?

Impleo Medical Inc.Lead Sponsor
~12 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top